Sammy Karam - Aug 3, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Aug 3, 2021
Transactions value $
-$372,800
Form type
4
Date filed
8/5/2021, 05:40 PM
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $607K +8K +34.89% $75.90 30.9K Aug 3, 2021 Direct
transaction ABT Common shares without par value Sale -$980K -8K -25.87% $122.50 22.9K Aug 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -8K -10.96% $0.00 65K Aug 3, 2021 Common Shares 8K $75.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.